Fasting plasma glucose (FPG), age, body mass index (BMI), and male sex are all associated with development of diabetes.
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.